Hard to Treat Diseases (HTDS)

[justfishing]

Company Overview

As of February 20, 2009, Hard to Treat Diseases, Inc. was acquired by Shenzhen Mellow Hope Pharm Industrial Co., Ltd. in reverse merger transaction. In June 2003, International Foam Solutions, Inc. changed its name to Hard to Treat Diseases, Inc. in connection with the completion of a share exchange agreement with Hard to Treat Diseases and T-19, Inc. Hard to Treat Diseases, Inc. holds the international marketing rights, except South Korea, to Tubercin, a patented immunostimulant developed for combating cancer and rheumatoid arthritis under medical patent. Tubercin promotes good health by enhancing the immune system. The nasal spray would be distributed through major holistic retailers and p...